XiFin, a provider of AI-driven revenue cycle management solutions, has made a strategic investment in Notable Systems as part of the healthcare automation company’s Series B financing. The investment accompanies a multi-year strategic AI alliance focused on developing purpose-built agentic AI capabilities for healthcare revenue cycle management.
The companies plan to combine Notable’s enterprise-grade document intelligence with XiFin’s revenue cycle data, healthcare expertise, and workflow orchestration capabilities. The resulting technology will be integrated across the XiFin Empower AI RCM ecosystem, which supports diagnostic, medical device, and pharmacy organizations.
The collaboration is designed to automate document-intensive processes involved in healthcare orders and claims. Notable’s AI agents will work with requisitions, prescriptions, medical records, payer correspondence, and other unstructured information that traditionally requires significant manual processing.
XiFin said the technology will extend automation across workflows ranging from patient registration and eligibility verification to clinical documentation, billing, payments, and appeals. The companies expect the combination to reduce manual touches and improve financial outcomes, particularly in complex billing environments.
An early example of the partnership is XiFin Empower DocExtract, which uses Notable’s document intelligence to extract, classify, split, label, and route incoming medical records, orders, and correspondence into appropriate revenue cycle workflows.
Notable Systems is also realigning its operations to increase investment in engineering, product innovation, and embedded delivery capabilities for major healthcare providers and RCM platforms. Its customers include Orthofix, National Seating & Mobility, and Advanced Diabetes Supply, a Cardinal Health subsidiary.
KEY QUOTES:
“XiFin has long applied AI, automation, and active intelligence across the revenue cycle. This alliance builds on that foundation by expanding the specialized capabilities available through XiFin Empower and accelerating our broader innovation roadmap. Our investment and multi-year commitment reflect both the importance of this work and XiFin’s continued leadership in shaping the next generation of intelligent revenue cycle management.”
Lâle White, Executive Chair and CEO of XiFin
“Our greatest successes have always come from deep, collaborative relationships with major healthcare partners. XiFin’s participation in our Series B is a meaningful vote of confidence in our team and our technology, and this strategic realignment lets us invest further in the embedded partnerships that have long differentiated Notable. Our strategic alliance with XiFin provides the foundation to accelerate innovation for years to come.”
Steve Johnson, CEO and Co-Founder of Notable Systems
